Essential Questions to Ask Your Nephrologist When Planning for Kidney Transplant
You should systematically ask your nephrologist about five critical domains: your medical eligibility and risk factors, the evaluation timeline and testing requirements, immunosuppression protocols and drug interactions, post-transplant monitoring expectations, and living versus deceased donor options.
Medical Eligibility and Risk Assessment
Start by understanding your specific candidacy status. Ask your nephrologist:
What is my current kidney function (creatinine clearance), and am I eligible for preemptive transplantation before starting dialysis? Patients with creatinine clearance around 30 mL/min/1.73m² should be introduced into transplant programs, and early referral may lead to preemptive transplantation—the ideal scenario achieved in 25% of living donor cases 1.
What are my specific cardiovascular risks, and what cardiac testing will I need? Cardiovascular disease is a major determinant of transplant outcomes 2.
Do I have any conditions that increase my surgical or immunological risk? This includes your body mass index, frailty status (biological age), history of malignancy, and viral status (hepatitis, HIV, Epstein-Barr virus) 3, 2.
What is my blood type and HLA tissue type, and how will this affect my wait time? ABO compatibility is mandatory to prevent hyperacute rejection, and HLA matching (particularly HLA-A, -B, and -DR antigens) significantly improves long-term outcomes 4. Under current allocation policies, you may receive offers for zero HLA mismatch kidneys or expanded criteria donor kidneys soon after listing 1.
Evaluation Timeline and Testing Requirements
Understanding the process prevents delays:
What specific tests do I need before being listed, and how long will the evaluation take? The evaluation should include assessment of pelvic vessels for anastomosis, genitourinary system evaluation, vascular access review, and screening for early malignancy detection 3, 5.
How often will I need re-evaluation while on the waiting list? If years pass before transplantation, thorough repeat evaluation is necessary when nearing the top of the list 1.
What is my immunological risk profile, and will I need a crossmatch test? The pretransplant crossmatch is one of the most important procedures, as it excludes donor organs from recipients with preexisting anti-donor immunity that would cause graft failure 4.
Immunosuppression and Drug Interactions
This is critical for post-transplant success:
What immunosuppressive medications will I take, and what are the major drug interactions I must avoid? Calcineurin inhibitors (cyclosporine, tacrolimus) have numerous dangerous interactions 4:
- Drugs that increase levels: non-dihydropyridine calcium channel blockers, imidazole antifungals, macrolide antibiotics
- Drugs that decrease levels: phenobarbital, phenytoin, carbamazepine, rifampicin
- Never combine azathioprine with allopurinol without dose adjustment—this can cause fatal bone marrow suppression 4
- HMG-CoA reductase inhibitors (statins) must be reduced by 50% or more when taking cyclosporine 4
Will I be on belatacept or standard calcineurin inhibitors? Belatacept may be used in immunologically low-risk patients with positive Epstein-Barr virus serology 6.
What are the signs of rejection I should watch for? Understand that rejection cannot be differentiated from other causes of dysfunction (acute tubular necrosis, infection, drug toxicity) without a biopsy 6.
Post-Transplant Monitoring and Long-Term Care
Clarify expectations for lifelong management:
What is the follow-up schedule, and what annual screening will I need? Regular long-term follow-up by experienced transplant physicians is essential 6. Annual screening should include:
- Dermatological examination
- Cardiovascular assessment
- Cancer screening (nodal examination, fecal occult blood, chest x-ray, gynecological/urological examination)
- Abdominal ultrasound of native and transplanted kidneys 6
How will you monitor for complications like calcineurin inhibitor toxicity and chronic rejection? Early detection of interstitial fibrosis and tubular atrophy is crucial 6.
What are my responsibilities for medication adherence and self-monitoring? Patients who receive extensive education about medications, monitoring, and responsibilities are more likely to succeed with self-management 7.
Living Versus Deceased Donor Options
Understand your pathways to transplantation:
Am I a candidate for living donor transplantation, and what are the advantages? Living donor transplantation offers better outcomes and shorter wait times 1.
What is my expected wait time for a deceased donor kidney based on my blood type and location? This varies significantly by region and blood type.
Should I consider expanded criteria donors or older donor kidneys? Decisions should not be based on histological findings alone, and optimization of hydration improves graft function 6.
Common Pitfalls to Avoid
- Don't wait until you're on dialysis to start the evaluation—early referral enables preemptive transplantation 1
- Maintain active communication with both your nephrologist and transplant center—this is essential for maintaining preparation during potentially years-long waits 1
- Understand that all suspected rejections require biopsy confirmation before treatment, as clinical indicators alone are unreliable 6